An article posted today on Forbes offers anecdotal and scientific—what little exists—pros and cons of using marijuana to treat people with autism as well as schizophrenia.
The lack of scientific research might change thanks to the Obama administration’s removal of bureaucratic hoops in studying various chemical found in the plant. In addition, the proposed CARERS Act promoting new applications of medical marijuana enjoys bipartisan support. As noted in the piece, numerous chemicals exist within a marijuana plant, so one could potentially be helpful while another harmful. One example says that heart patients don’t take foxglove, they take digoxin–a chemical found in the foxglove plant.
The article also shares personal success stories and grassroots organizations convinced of the drug’s benefits in treating autism.